Federal Awards · XLCARE PHARMACEUTICALS INC · Award

NEW AWARD FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS NOVEMBER 11, 2…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID
36E79723D0027
Contractor
XLCARE PHARMACEUTICALS INC
Sub-agency / office
Department of Veterans Affairs
Award amount
$0
Period of performance
Nov 11, 2023 – —
NAICS
325412 — Pharmaceutical Preparation Manufacturing
PSC
PSC 6505
Competition
FULL AND OPEN COMPETITION · Set-aside: NO SET ASIDE USED. · 7 offers
Pricing
FIRM FIXED PRICE
Financial breakdown
Obligated $0 · Potential value $54,110,891 · Latest action obligation $0

Public award description

NEW AWARD FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS NOVEMBER 11, 2023 THROUGH NOVEMBER 10, 2024 WITH FOUR ONE YEAR OPTIONS.

Most recent · Modification P00004 · Sep 3, 2026 · $0 action obligation · MODIFICATION TO IMPLEMENT EO 14398 DEI DISCRIMINATION. · 36E79723D0027

Modification P00003 · Sep 16, 2025 · $0 action obligation · EXERCISE OPTION YEAR 2 EFFECTIVE 11/11/2025 THROUGH 11/10/2026 FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PRICES REMAIN UNCHANGED. · 36E79723D0027

Modification P00002 · Sep 25, 2024 · $0 action obligation · EXERCISE OPTION YEAR ONE EFFECTIVE 11/11/2024 THROUGH 11/10/205 FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PRICES REMAIN UNCHANGED. · 36E79723D0027

Modification P00001 · Feb 9, 2024 · $0 action obligation · COST RECOVERY FEE AND SUBMISSION OF QUARTERLY SALES REPORT CHANGES EFFECTIVE 2/9/2024 FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. · 36E79723D0027

Modification 0 · Aug 14, 2023 · $0 action obligation · NEW AWARD FOR GABAPENTIN CAPSULES WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS NOVEMBER 11, 2023 THROUGH NOVEMBER 10, 2024 WITH FOUR ONE YEAR OPTIONS. · 36E79723D0027

Source: USAspending.gov

Related intelligence

Related Federal Awards

  • Same agency and NAICS · 36C24026K1010 — EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY · MCKESSON CORPORATION · Department of Veterans Affairs · $1,194,619,137
  • Same agency and NAICS · 36C25926F0310 — EMERGENCY PHARMACY CARVYKTI FOR RMR · JANSSEN BIOTECH INC · Department of Veterans Affairs · $384,719
  • Same agency and NAICS · 36C26226N0738 — Federal award — Department of Veterans Affairs · BRISTOL-MYERS SQUIBB COMPANY · Department of Veterans Affairs · $364,139
  • Same agency and NAICS · 36C24626P0824 — OMINCELL IVX WORKFLOW MANAGEMENT (4 DEVICES), IVX LABEL SFW, IVX COLOR PRINTER, IVX ZEBRA BARCODE SCANNER, · TRILLAMED LLC · Department of Veterans Affairs · $268,200
  • Same agency and NAICS · 36C77026N0048 — Federal award — Department of Veterans Affairs · MERZ PHARMACEUTICALS, LLC · Department of Veterans Affairs · $236,612
  • Same agency and NAICS · 36C24626N1034 — Federal award — Department of Veterans Affairs · PARTNER THERAPEUTICS, INC. · Department of Veterans Affairs · $72,362

Browse federal awards · Browse contractors

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

SmartSoloChatGPTClaudePerplexityGrokGemini

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.